Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Addus HomeCare Corporation

11.4% sales growth and 7.25% return on equity

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.

Addus HomeCare Corporation’s sales growth this year is expected to be 18% and 12% for next year.

Year-on-year quarterly revenue growth grew by 14.8%, now sitting on 760.81M for the twelve trailing months.

Addus HomeCare Corporation’s sales growth for the next quarter is 11.4%. The company’s growth estimates for the present quarter and the next is 1.4% and 11.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.25%.

Volatility

Addus HomeCare Corporation’s last day, last week, and last month’s average volatility was a negative 1.92%, a positive 1.79%, and a positive 0.82%, respectively.

Addus HomeCare Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 3.40%, 3.35%, and 3.20%, respectively.

Addus HomeCare Corporation’s Stock Yearly Top and Bottom Value

Addus HomeCare Corporation’s stock is valued at $112.99 at 13:22 EST, under its 52-week high of $117.77 and way higher than its 52-week low of $43.13.

Addus HomeCare Corporation’s Moving Average

Addus HomeCare Corporation’s worth is higher than its 50-day moving average of $102.73 and way above its 200-day moving average of $96.84.

2. Luminex Corporation

27% sales growth and 3.75% return on equity

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide.

Luminex Corporation’s sales growth this year is expected to be 22.7% and 15.5% for next year.

Year-on-year quarterly revenue growth grew by 34.8%, now sitting on 396.5M for the twelve trailing months.

Luminex Corporation’s sales growth for the next quarter is 27%. The company’s growth estimates for the ongoing quarter and the next is 62.5% and 1900%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.75%.

Volatility

Luminex Corporation’s last day, last week, and last month’s average volatility was a negative 3.00%, a positive 0.43%, and a positive 0.56%, respectively.

Luminex Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 4.15%, 3.85%, and 4.00%, respectively.

Luminex Corporation’s Stock Yearly Top and Bottom Value

Luminex Corporation’s stock is valued at $24.19 at 13:22 EST, way below its 52-week high of $41.69 and way above its 52-week low of $20.61.

Luminex Corporation’s Moving Average

Luminex Corporation’s worth is higher than its 50-day moving average of $23.22 and way below its 200-day moving average of $27.46.

3. DexCom, Inc.

21.9% sales growth and 20.42% return on equity

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

DexCom, Inc.’s sales growth this year is anticipated to be 29.4% and 21.8% for next year.

Year-on-year quarterly revenue growth grew by 26.4%, now sitting on 1.82B for the twelve trailing months.

DexCom, Inc.’s sales growth for the next quarter is 21.9%. The company’s growth estimates for the current quarter and the next is a negative 20% and 13.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.42%.

Volatility

DexCom, Inc.’s last day, last week, and last month’s average volatility was a negative 2.79%, a negative 0.28%, and a positive 0.25%, respectively.

DexCom, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.39%, 2.73%, and 3.66%, respectively.

DexCom, Inc.’s Stock Yearly Top and Bottom Value

DexCom, Inc.’s stock is valued at $354.23 at 13:22 EST, way below its 52-week high of $456.23 and way higher than its 52-week low of $182.07.

DexCom, Inc.’s Moving Average

DexCom, Inc.’s value is above its 50-day moving average of $338.19 and below its 200-day moving average of $389.33.

4. Southern Missouri Bancorp, Inc.

10.3% sales growth and 11.83% return on equity

Southern Missouri Bancorp, Inc. operates as the bank holding company for Southern Bank that provides banking and financial services to individuals and corporate customers in the United States.

Southern Missouri Bancorp, Inc.’s sales growth this year is expected to be 9.3% and a negative 4% for next year.

Year-on-year quarterly revenue growth grew by 17.6%, now sitting on 92.77M for the twelve trailing months.

Southern Missouri Bancorp, Inc.’s sales growth is a negative 0% for the ongoing quarter and 10.3% for the next. The company’s growth estimates for the present quarter and the next is 6% and 25.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.83%.

Volatility

Southern Missouri Bancorp, Inc.’s last day, last week, and last month’s average volatility was a positive 0.10%, a negative 0.82%, and a positive 0.19%, respectively.

Southern Missouri Bancorp, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.72%, 4.14%, and 2.79%, respectively.

Southern Missouri Bancorp, Inc.’s Stock Yearly Top and Bottom Value

Southern Missouri Bancorp, Inc.’s stock is valued at $30.93 at 13:22 EST, way below its 52-week high of $38.98 and way higher than its 52-week low of $17.30.

Southern Missouri Bancorp, Inc.’s Moving Average

Southern Missouri Bancorp, Inc.’s worth is above its 50-day moving average of $29.82 and way above its 200-day moving average of $24.96.

5. ServiceNow

24% sales growth and 34.15% return on equity

ServiceNow, Inc. provides enterprise cloud computing solutions that defines, structures, consolidates, manages, and automates services for enterprises worldwide.

ServiceNow’s sales growth this year is anticipated to be 29.4% and 24.9% for next year.

Year-on-year quarterly revenue growth grew by 30%, now sitting on 4.22B for the twelve trailing months.

ServiceNow’s sales growth for the next quarter is 24%. The company’s growth estimates for the present quarter and the next is 9.4% and 20%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.15%.

Volatility

ServiceNow’s last day, last week, and last month’s average volatility was a positive 0.26%, a negative 0.52%, and a positive 0.11%, respectively.

ServiceNow’s last day, last week, and last month’s high and low average amplitude percentage was 1.35%, 2.38%, and 2.49%, respectively.

ServiceNow’s Stock Yearly Top and Bottom Value

ServiceNow’s stock is valued at $544.20 at 13:22 EST, under its 52-week high of $566.74 and way higher than its 52-week low of $238.93.

ServiceNow’s Moving Average

ServiceNow’s value is above its 50-day moving average of $531.41 and way higher than its 200-day moving average of $475.50.

Previous days news about ServiceNow

According to The Wall Street Journal on Monday, 28 December, "Shares of companies that provide cloud services, such as Snowflake Inc. and ServiceNow Inc., run by former SAP CEO Bill McDermott, have surged during the pandemic as more businesses have embraced such services. "

LEAVE A REPLY

Please enter your comment!
Please enter your name here